Literature DB >> 9223654

Delta-6-desaturase and delta-5-desaturase in human Hep G2 cells are both fatty acid interconversion rate limiting and are upregulated under essential fatty acid deficient conditions.

T Melin1, A Nilsson.   

Abstract

Essential fatty acids are interconverted by desaturases and elongases to eicosanoid precursors. In essential fatty acid deficiency (EFAD) an increased hepatic interconversion of linoleic acid (18:2) to arachidonic acid (20:4n-6) has been demonstrated in vivo. We now cultured Hep G2 cells under EFAD conditions. 20:3n-6 appeared in EFAD cells, but also in controls. After adding 14C-18:2 to the medium, interconversion products and their distribution in different lipids were studied by HPLC. When trace amounts 18:2 were incubated, 38% were converted by the EFAD cells after 21 h, vs 6% by controls. 20% was converted to 20:4 by EFAD cells vs 14% by controls. EFAD cells preferentially distributed more 18:2 and conversion products to neutral fats and to phosphatidyl ethanolamine, but less to cardiolipin than controls did, when incubated with trace amount 18:2, but not with 1 mM 18:2. A relative accumulation of radioactivity in 20:3 was observed. In conclusion; in EFAD Hep G2 cells delta-6- and delta-5-desaturase both were found to be upregulated and eicosanoid precursors were distributed more into phosphatidyl ethanolamine. Delta-5-desaturase had a rate limiting property as well as delta-6-desaturase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223654     DOI: 10.1016/s0952-3278(97)90596-2

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  8 in total

1.  Early development of essential fatty acid deficiency in rats: fat-free vs. hydrogenated coconut oil diet.

Authors:  Pei-Ra Ling; Charlotte E De Leon; Hau Le; Mark Puder; Bruce R Bistrian
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-08-02       Impact factor: 4.006

2.  Dietary arachidonic acid and docosahexaenoic acid regulate liver fatty acid desaturase (FADS) alternative transcript expression in suckling piglets.

Authors:  Vasuki Wijendran; Ian Downs; Cynthia Tyburczy Srigley; Kumar S D Kothapalli; Woo Jung Park; Bryant S Blank; J Paul Zimmer; C M Butt; Norman Salem; J Thomas Brenna
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-08-26       Impact factor: 4.006

Review 3.  Elevated production of docosahexaenoic acid in females: potential molecular mechanisms.

Authors:  Alex P Kitson; Chad K Stroud; Ken D Stark
Journal:  Lipids       Date:  2010-02-12       Impact factor: 1.880

4.  Fads1 and 2 are promoted to meet instant need for long-chain polyunsaturated fatty acids in goose fatty liver.

Authors:  Rashid H Osman; Long Liu; Lili Xia; Xing Zhao; Qianqian Wang; Xiaoxian Sun; Yihui Zhang; Biao Yang; Yun Zheng; Daoqing Gong; Tuoyu Geng
Journal:  Mol Cell Biochem       Date:  2016-06-25       Impact factor: 3.396

5.  Pharmacological modulation of fatty acid desaturation and of cholesterol biosynthesis in THP-1 cells.

Authors:  P Risé; S Ghezzi; M G Levati; R Mirtini; C Colombo; C Galli
Journal:  Lipids       Date:  2003-08       Impact factor: 1.880

6.  Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes.

Authors:  Y Min; K Ghebremeskel; C Lowy; B Thomas; M A Crawford
Journal:  Diabetologia       Date:  2003-11-22       Impact factor: 10.122

7.  Effects of cigarette smoke on cell viability, linoleic acid metabolism and cholesterol synthesis, in THP-1 cells.

Authors:  Silvia Ghezzi; Patrizia Risé; Stefania Ceruti; Claudio Galli
Journal:  Lipids       Date:  2007-06-06       Impact factor: 1.880

8.  Disturbances in essential fatty acid metabolism in patients receiving long-term home parenteral nutrition.

Authors:  Pei-Ra Ling; Mario Ollero; Lalita Khaodhiar; Karen McCowen; Mary Keane-Ellison; Ann Thibault; Nicholas Tawa; Bruce R Bistrian
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.